Applications of nanomaterials for cancer treatment: Recent patents review

Recent Patents on Nanomedicine

Volumn 3, Issue 2, 2013, Pages 75-82

  Yang, Yamin ^a   Wang, Hongjun ^a  

^a Stevens Institute of Technology   (United States)

Author keywords

Cancer therapy; Drug delivery; Gold nanostructures; MNPs; Nanoparticles; Nanotechnology

Indexed keywords

CARBON NANOTUBE; GOLD NANOPARTICLE; LIPOSOME; MAGNETIC NANOPARTICLE; NANOMATERIAL; PHOTOSENSITIZING AGENT; QUANTUM DOT;

CANCER RADIOTHERAPY; CANCER THERAPY; CELL KILLING; CELL MIGRATION; CELL VIABILITY ASSAY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ELECTROMAGNETIC FIELD; FIBROSARCOMA; IMMUNOGENICITY; MAGNETIC FIELD; MICELLE; MULTIDRUG RESISTANCE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW;

EID: 84990314500     PISSN: 18779123     EISSN: 18779131     Source Type: Journal    
DOI: 10.2174/1877912304666140129000556     Document Type: Review

References (60)

1. Cancer Facts & Figures. Am Cancer Soc 2013.
2. [2] Yang Y, Wang H. Perspectives of nanotechnology in minimally invasive therapy of breast cancer. J Healthc Eng 2013; 4: 67-86.
3. [3] Vlastos G, Verkooijen HM. Minimally invasive approaches for diagnosis and treatment of early-stage breast cancer. Oncologist 2007; 12: 1-10.
4. [4] Hakimi AA, Feder M, Ghavamian R. Minimally invasive approaches to prostate cancer: a review of the current literature. Urol J 2007; 4: 130-7.
5. [5] Riadh WY, Habash RB. Thermal therapy, Part III: ablation techniques. Crit Rev Biomed Eng 2007; 35: 37-121.
6. [6] Barreto J, O’Malley W, Kubeil M, Graham B, Stephan H, Spiccia L. Nanomaterials: applications in cancer imaging and therapy. Adv Mater 2011; 23: H18-40.
7. [7] Wang R, Billone PS, Mullett WM. Nanomedicine in action: An overview of cancer nanomedicine on the market and in clinical trials. J Nanomater 2013; 2013: 12.
8. [8] Ruoslahti E, Bhatia SN, Sailor MJ. Targeting of drugs and nanoparticles to tumors. J Cell Biol 2010; 188: 759-68.
9. [9] Cho K, Wang X, Nie S, Chen ZG, Shin DM. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 2008; 14: 1310-6.
10. [10] Praetorius NP, Mandal TK. Engineered nanoparticles in cancer therapy. Rec Pat Drug Deliv Formul 2007; 1: 37-51.
11. [11] Antunes AMDS, Alencar MSDM, Da Silva CH, Nunes J, Mendes FML. Trends in nanotechnology patents applied to the health sector. Rec Pat Nanotechnol 2012; 6: 29-43.
12. [12] Abdulkarim MF, Heard C, Alany GR. An overview of recent patents on nanoparticles for drug delivery across the blood brain barrier. Rec Pat Nanomed 2012; 2: 45-51.
13. [13] Voliani V, Signore G, Nifosi R, Ricci F, Luin S, Beltram F. Smart delivery and controlled drug release with gold nanoparticles: new frontiers in nanomedicine. Rec Pat Nanomed 2012; 11: 34-44.
14. [14] Conde J, Doria G, Baptista P. Noble metal nanoparticles applications in cancer. J Drug Deliv 2012; 2012: 12.
15. [15] Mesbahi A. A review on gold nanoparticles radiosensitization effect in radiation therapy of cancer. Reports Pract Oncol Radiother 2010; 15: 176-80.
16. [16] Krishnan S, Diagaradjane P, Cho SH. Nanoparticle-mediated thermal therapy: evolving strategies for prostate cancer therapy. Int J Hyperthermia 2010; 26: 775-89.
17. [17] Slatkin DN, Digiglio FS. Methods of enhancing radiation effects with metal nanoparticles. US 20050256360 A1, 2005.
18. [18] Jie Chen WR. Targeted nanoparticles for cancer diagnosis and treatment. US 20100034735 A1, 2010.
19. [19] Oo MK, Yang X, Du H, Wang H. 5-aminolevulinic acidconjugated gold nanoparticles for photodynamic therapy of cancer. Nanomedicine 2008; 3(6): 777-86.
20. [20] Oo MK, Yang Y, Hu Y, Gomez M, Du H, Wang H. Gold nanoparticle-enhanced and size-dependent generation of reactive oxygen species from protoporphyrin IX. ACS Nano 2012; 6: 1939-47.
21. [21] Kah JCY, Wan RCY, Wong KY, Mhaisalkar S, Sheppard CJR, Olivo M. Combinatorial treatment of photothermal therapy using gold nanoshells with conventional photodynamic therapy to improve treatment efficacy: an in vitro study. Lasers Surg Med 2008; 40: 584-9.
22. [22] Carpin LB, Bickford LR, Agollah G, et al. Immunoconjugated gold nanoshell-mediated photothermal ablation of trastuzumab-resistant breast cancer cells. Breast Cancer Res Treat 2011; 125: 27-34.
23. [23] Kuo W-S, Chang C-N, Chang Y-T, et al. Gold nanorods in photodynamic therapy, as hyperthermia agents, and in near-infrared optical imaging. Angew Chem Int Ed Engl 2010; 49: 2711-5.
24. [24] Day ES, Thompson P, Zhang L, et al. Nanoshell-mediated photothermal therapy improves survival in a murine glioma model. J Neurooncol 2011; 104(1): 55-63
25. [25] Huang X, Jain PK, El-Sayed IH, El-Sayed MA. Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine (Lond), 2007; 2: 681-93.
26. [26] Huang X, El-Sayed IH, Qian W, El-Sayed M. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J Am Chem Soc 2006; 128: 2115-20.
27. [27] Huang X, Jain PK, El-Sayed IH, El-Sayed M. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med Sci 2008; 23: 217-28.
28. [28] Krishnan S, Dagaradjane P, Schwatrz JA, Wang JC. Treatments of disease or disorders using nanoparticles for focused hyperthermia to increase therapy efficacy. WO 2009091597 A2, 2009.
29. [29] Tiwari P, Vig K, Dennis V, Singh S. Functionalized gold nanoparticles and their biomedical applications. Nanomaterials 2011; 1: 31-63.
30. [30] Goudoulas BT. Polymers and biopolymers as drug delivery systems in nanomedicine. Rec Pat Nanomed 2012; 2: 52-61.
31. [31] Au J, Wientjes M. Tumor targeting drug-loaded particles. US 20060034925 A1, 2006.
32. [32] Gelperina S, Kreuter J, Sabel BA, Schroder U. Use of drug-loaded nanoparticles for the treatment of cancers. WO 2000074658 A1, 2000.
33. [33] Yuan Z-M, Seo S-J. Methods and compositions for nanoparticlemediated cancer cell-targeted delivery. WO 2011088456 A3, 2011.
34. Mcewan JF, Russell-Jones GJ. Amplification of folate-mediated targeting to tumor cells using nanoparticles. EP 1206251 A1, 2002.
35. [35] Shroff K, Vidyasagar A. Polymer nanoparticles: newer strategies towards targeted cancer therapy. J Phys Chem Biophys 2013; 3: 4-6.
36. [36] Khan D, Favela S, Muniz A, Blakeman A. Recent patents on common modifications made to traditional micellar-based chemotherapeutics designed to improve drug delivery. Rec Pat Nanomed 2013; 3: 21-5.
37. [37] Lavasanifar A, Xiong X. Novel ligand guided block copolymers for targeted drug delivery. US 20100137206 A1, 2010.
38. [38] Bae YH, Na K, Lee ES. pH-sensitive polymeric micelles for drug delivery. US 7229973 B2, 2007.
39. [39] Andresen TL, Jensen SS, Jorgensen K. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. Prog Lipid Res 2005; 44: 68-97.
40. [40] Brandl M, Fichtner I, Reszka R, Warnke G. Liposomeencapsulated taxol, its preparation and its use. US 6090955 A, 2000.
41. [41] Boulikas T. Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes. WO 2001034130 A1, 2001.
42. [42] Ayre A, Kadam V, Dand N, Patel P. Polymeric micelles as a drug carrier for tumor targeting. Chronicles Young Sci 2013; 4: 94.
43. [43] Caldorera-Moore M, Guimard N, Shi L, Roy K. Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers. Exp Opin Drug Deliv 2010; 7: 479-95.
44. [44] Yu J, Huang D-Y, Yousaf MZ, Hou Y-L, Gao S. Magnetic nanoparticle-based cancer therapy. Chinese Phys B, 2013; 22: 027506.
45. [45] Kim C-O, Kim J-H, Huang Y-Q, Park S-I. Radioactive magnetic fluids for treatment or diagnosis of cancer, process for preparing them and use thereof. US 20050019257 A1, 2005.
46. [46] Handy ES, Ivkov R, Ellis-Busby D, Foreman A. Thermotherapy via targeted delivery of nanoscale magnetic particles. US 7074175 B2, 2005.
47. [47] Yu J, Huang D-Y, Yousaf MZ, Hou Y-L, Gao S. Magnetic nanoparticle-based cancer therapy. Chinese Phys B 2013; 22: 027506.
48. [48] Mahmoudi M, Laurent S, Shokrgozar MA, Hosseinkhani M. Toxicity evaluations of superparamagnetic iron oxide nanoparticles: cell “vision” versus physicochemical properties of nanoparticles. ACS Nano 2011; 5: 7263-76.
49. [49] Markides H, Rotherham M, Haj EAJ. Biocompatibility and toxicity of magnetic nanoparticles in regenerative medicine. J Nanomater 2012; 2012: 1-11.
50. [50] Maldiney T, Scherman D, Richard C. Persistent luminescence nanoparticles for diagnostics and imaging. In: Functional Nanoparticles for Bioanalysis, Nanomedicine, and Bioelectronic Devices Volume 2. Washington, DC: American Chemical Society, 2012; 1113: 1-25.
51. [51] Dey NS, Rao MEB. Quantum dot: novel carrier for drug delivery. Int J Res Pharm Biomed Sci 2011; 2: 448-58.
52. [52] Luo G, Long J, Zhang B, et al. Quantum dots in cancer therapy. Expert Opin Drug Deliv 2012; 9: 47-58.
53. [53] Chen J. Use of photoluminescent nanoparticles for photodynamic therapy. US 20020127224 A1, 2005.
54. [54] Biris AS, Xu Y, Wang D. Multifunctional Fe3O4 cored magneticquantum dot fluorescent nanocomposites for rf nano-hyperthermia of cancer cells. US 20110237862 A1, 2011.
55. [55] Ho Y-P, Leong KW. Quantum dot-based theranostics. Nanoscale 2010; 2: 60-8.
56. [56] Fang M, Peng C-W, Pang D-W, Li Y. Quantum dots for cancer research: current status, remaining issues, and future perspectives. Cancer Biol Med 2012; 9: 151-63.
57. [57] Zhang W, Zhang Z, Zhang Y. The application of carbon nanotubes in target drug delivery systems for cancer therapies. Nanoscale Res Lett 2011; 6: 555.
58. [58] Madani SY, Naderi N, Dissanayake O, Tan A, Seifalian AM. A new era of cancer treatment: carbon nanotubes as drug delivery tools. Int J Nanomedicine 2011; 6: 2963-79.
59. [59] Harrison RG, Resasco DE. Compositions and methods for cancer treatment using targeted carbon nanotubes. US20130183354, 2011.
60. [60] Panchapakesan B. Carbon nanotube nanobomb. WO 2008082374 A2, 2011.